Influenza Diagnostic Global Market Report 2024 – By Size, Share, Trends, Demand, Forecast To 2033 | F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc

The influenza diagnostic market size is expected to see strong growth in the next few years. It will grow to $3.68 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%.  The growth in the forecast period can be attributed to continuing seasonal influenza, point-of-care testing, remote and home testing, digital health integration. Major trends in the forecast period include point-of-care testing, molecular diagnostics, antigen-based tests, multiplex assays, automation and robotics.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

Scope Of Influenza Diagnostic Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Influenza Diagnostic Market Overview

Market Drivers –
Rapid diagnostic tests are expected to propel the growth of the influenza diagnostic market going forward. Diagnostic tests are medical procedures or tools used to confirm or rule out a condition or disease. Rapid influenza diagnostic tests (RIDTs) can detect influenza viral antigens in 10-15 minutes with moderate sensitivity (50-70%). For instance, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, during September 2020 to May 2021, in the United States, 1,675 (0.2%) of 818,939 respiratory specimens tested by U.S. clinical laboratories were positive for an influenza virus. Thus, rapid diagnostic tests are driving the growth of the influenza diagnostic market.

The influenza diagnostic market covered in this report is segmented –
1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests
2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests
3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

Get an inside scoop of the influenza diagnostic market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

Regional Insights –
North America was the largest region in the influenza diagnostics market in 2023. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Key Companies –
Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

Table of Contents
1. Executive Summary
2. Influenza Diagnostic Market Report Structure
3. Influenza Diagnostic Market Trends And Strategies
4. Influenza Diagnostic Market – Macro Economic Scenario
5. Influenza Diagnostic Market Size And Growth
…..
27. Influenza Diagnostic Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Read Related Topics:
https://goodprnews.com/dermatology-medical-lasers-global-market-size/
https://goodprnews.com/dry-condensed-and-evaporated-dairy-products-global-market-size/
https://goodprnews.com/engine-turbine-and-power-transmission-equipment-global-market-size/
https://topprnews.com/dermatology-medical-lasers-global-market-share/
https://topprnews.com/dry-condensed-and-evaporated-dairy-products-global-market-share/
https://topprnews.com/engine-turbine-and-power-transmission-equipment-global-market-share/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model